Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Short term Debt (2016 - 2025)

Historic Short term Debt for Mimedx (MDXG) over the last 9 years, with Q3 2025 value amounting to $1.4 million.

  • Mimedx's Short term Debt fell 5192.31% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 5192.31%. This contributed to the annual value of $1.0 million for FY2024, which is 0.0% changed from last year.
  • Per Mimedx's latest filing, its Short term Debt stood at $1.4 million for Q3 2025, which was down 5192.31% from $1.2 million recorded in Q2 2025.
  • Over the past 5 years, Mimedx's Short term Debt peaked at $2.9 million during Q3 2024, and registered a low of $1.0 million during Q4 2023.
  • Moreover, its 3-year median value for Short term Debt was $1.2 million (2025), whereas its average is $1.5 million.
  • Within the past 5 years, the most significant YoY rise in Mimedx's Short term Debt was 1250.0% (2025), while the steepest drop was 5192.31% (2025).
  • Over the past 3 years, Mimedx's Short term Debt (Quarter) stood at $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then surged by 37.5% to $1.4 million in 2025.
  • Its Short term Debt was $1.4 million in Q3 2025, compared to $1.2 million in Q2 2025 and $1.1 million in Q1 2025.